On World AIDS Day, SAMHSA renews commitment to end the HIV epidemic
Impact on your practice
This is messaging and visibility for SAMHSA's existing HIV elimination goals. While not a policy change, it reinforces federal priority on integrated care for people with HIV and co-occurring mental illness, which could influence future grant opportunities.
Key facts
World AIDS Day 2020 messaging reaffirming SAMHSA's commitment to ending HIV epidemic
Acknowledges COVID-19 pandemic exacerbating challenges for people with HIV, SUD, and mental illness
No new funding mechanisms, grants, or policy changes described
Thematic alignment with integrated mental health and SUD treatment priorities
Therapy Companion analysis
This SAMHSA statement signals sustained federal prioritization of integrated HIV/substance use/mental health treatment, which directly affects your reimbursement landscape and grant funding opportunities. While no new funding mechanisms are announced here, SAMHSA's explicit goal to ensure every beneficiary receives HIV testing, post-test counseling, and treatment linkage means that if you receive SAMHSA grants or serve SAMHSA-funded populations, you should expect increasing documentation requirements around HIV screening protocols and referral pathways. In FY2020, SAMHSA grantees screened 19,000 individuals and linked 564 newly identified HIV-positive people to treatment—these are measurable performance metrics that will likely become part of grant compliance audits. For solo practitioners and small agencies, this doesn't directly change your Medicaid or private insurance contracts, but it does signal that HIV screening will become standard of care expectation across SUD and mental health settings. If you bill Medicaid or Medicare for substance use disorder treatment or mental health services, anticipate payer expectations that you document HIV risk assessment and screening, especially for patients with injection drug use history. The emphasis on 'virtual' testing alternatives and 'oral fluid testing' acknowledges pandemic-era adaptations that may persist in coverage policies—your clinical documentation should reflect these options when clinically appropriate. SAMHSA's Technology Transfer Centers are offering real-time technical assistance to grantees, meaning if your agency holds a SAMHSA grant, you have free resources to implement these screening and linkage protocols without additional compliance burden.
Background
Since 2019, the Trump administration's 'Ending the Epidemic: A Plan for America' positioned HIV elimination as a measurable public health goal, with SAMHSA as a lead agency alongside CDC and HRSA. The COVID-19 pandemic disrupted HIV testing and treatment continuity, creating a documented gap in screening and linkage services. This December 2020 statement reasserts federal commitment to HIV prevention and treatment within the substance use and mental health treatment infrastructure, recognizing that people with untreated SUD and mental illness face disproportionate HIV risk through high-risk sexual practices and injection drug use. The statement frames HIV screening and treatment linkage as core mission functions for SAMHSA-funded providers, not optional add-ons. This aligns with broader harm reduction and integrated care models that mental health and SUD practitioners have increasingly adopted, but now with federal agency endorsement and measurement expectations.
What you should do
If your practice or agency receives SAMHSA grants: audit your current HIV screening protocol and ensure 100% of SUD and mental health beneficiaries are offered testing or documented refusal. Review whether you're tracking 'linkage to treatment' for positive cases and prepare this data for grant compliance reviews.
Review your patient intake and assessment documentation templates to confirm you're documenting HIV risk factors (injection drug use, sexual practices, intoxication-related impaired judgment) and your screening/referral process. SAMHSA's November 2020 'Prevention and Treatment of HIV among People Living with Substance Use and/or Mental Disorders' guide should inform your clinical protocols.
If you work in a Medicaid-accepting practice, proactively document your HIV screening approach in clinical records and ensure your billing reflects screening and counseling CPT codes when applicable (99401-99404 for prevention counseling; 86703 for HIV antibody testing). State Medicaid programs will likely align with SAMHSA priorities, increasing payer expectations for this documentation.
Familiarize yourself with SAMHSA's Technology Transfer Centers and Substance Abuse and HIV Prevention Navigator Program resources (free technical assistance). If your agency qualifies for SAMHSA funding, leverage these to reduce implementation costs for integrated screening and linkage protocols.
Document your current referral pathways to HIV treatment specialists, infectious disease providers, and PrEP prescribers. SAMHSA's goal includes referral to pre-exposure prophylaxis for HIV-negative individuals, so ensure you can articulate your referral network if audited.
Notable excerpts
"People with mental or substance use disorders are at an increased risk of HIV in the form of high-risk drug use behaviors, particularly injection drug use, and high-risk sexual practices that frequently occur during intoxication and in the situation of untreated mental illness. Treating substance use disorder and mental disorder is a form of HIV prevention." (SAMHSA, December 1, 2020)
"Our eventual goal is to ensure that every beneficiary of SAMHSA programming receives an HIV test, post-test counseling, and linkage to treatment or prevention services." (SAMHSA, December 1, 2020)
"In FY2020, SAMHSA grantees screened nearly 19,000 individuals for HIV, including 577 newly identified HIV-positive people, and linked 564 of those people to lifelong treatment." (SAMHSA, December 1, 2020)
View full source text
Policy changes drive denial patterns
Therapy Companion tracks both: the policy shifts on this page and the denial patterns hitting your claims.
Related policy changes
One Student's Quick Thinking Shows Coordinated Action Through SAMHSA Program on Youth Mental Health Works
SAMHSA funding for school-based programs like Project AWARE generates referrals to therapists and expands youth access to mental health services. Therapists should understand these pipeline programs when engaging with schools.
On World AIDS Day, SAMHSA reaffirms commitment to Ending HIV Epidemic with support from partners
This signals federal funding and grant opportunities for therapists and agencies in high-burden HIV areas, particularly around integrated testing and treatment linkage. Therapists in targeted geographic areas should monitor MAI grant cycles.
Release of the 2024 National Survey on Drug Use and Health: Leveraging the Latest Substance Use and Mental Health Data to Make America Healthy Again
NSDUH data releases inform federal policy direction and funding priorities for behavioral health. Therapists should understand these epidemiological trends as they shape reimbursement, regulatory focus, and workforce demand.
New SAMHSA Guide Highlights HIV Prevention and Treatment for People with Substance Use and/or Mental Disorders
This SAMHSA clinical guidance can help therapists improve outcomes for high-risk populations with co-occurring conditions. It may also inform insurance companies' expectations for evidence-based treatment, potentially affecting prior authorization decisions.